Industry | Health care |
---|---|
Founded | 1981 |
Headquarters | Franklin, Tennessee, United States |
Area served
|
United States, Brazil, France, Germany |
Key people
|
|
Services | Disease management |
Revenue | US$742,183,000 (2014) |
Operating income
|
US$7,433,000 (2014) |
Profit | US$5,561,000 (2014) |
Number of employees
|
2,500+ (2015) |
Website | healthways |
Healthways is a well-being improvement company founded in 1981 and headquartered in Franklin, Tennessee.
In 2003, the company topped a list of "America's fastest-growing small companies," based on earnings/share growth, revenue growth, and total return. The company's name was changed from American Healthways (NASDAQ: AMHC) to "Healthways" (NASDAQ: HWAY) in 2006 in order to better compete for business outside the United States. In 2009 Healthways acquired HealthHonors, a behavior economics company that specializes in behavior change science and use of incentives.
In 2010, Blue Zones and Healthways teamed up to create, support, and sustain a national movement to improve community health and well-being by leading a city-by-city environment transformation with collaboration from both the public and private sectors.
In 2011, Healthways acquired Navvis & Company, a St. Louis-based firm providing strategic counsel and change management services both to enable its healthcare system clients to become future-ready clinical enterprises and to align the incentives for all stakeholders. Their partnership is now called Navvis Healthways.
In 2013, Healthways and The Lampo Group, Inc. — headed by Dave Ramsey — entered into an exclusive agreement for Healthways to deliver the CORE Financial Wellness program as part of its Well-Being Improvement Solution. This program is known as Healthways Financial Well-Being, Powered by Dave Ramsey. Also in 2013, Healthways contracted with Dean Ornish to operate and license his Lifestyle Management Programs. The agreement enabled the company to offer programs for changing lifestyles in order to prevent, treat and reverse certain chronic diseases.
Healthways currently operates eight Well-Being Improvement Centers (WBICs) across the US, and three international facilities.
QuitNet is an online smoking cessation system emphasizing social support as a mechanism for behavior change. The system originated at Boston University's School of Public Health in 1995 as a demonstration project and was spun-out as a for-profit entity in 2000. The company was later merged along with SilverSneakers and others to form Axia Health Management, Inc. and ultimately acquired by Healthways in 2006.
MeYou Health is a subsidiary of Healthways. Daily Challenge, their core product, is an interactive social gaming program designed to suggest slight changes in lifestyle to improve well-being. It incorporates Walkadoo, a wireless pedometer program, a Well-Being Tracker, to monitor changes in lifestyle, Hello 200, a social community element to help users find ways to reduce 200 calories a day-the amount typically needed to create greater fitness, and Quitnet, an online smoking cessation system.
2016-05-03 | Reiterated Rating | Jefferies Group | Hold | $13.00 |
2016-04-30 | Reiterated Rating | Barrington Research | Buy | |
2016-04-29 | Lower Price Target | Barrington Research | Outperform | $15.00 to $14.00 |
2016-04-29 | Reiterated Rating | FBR & Co. | Buy | |
2016-04-29 | Reiterated Rating | FBR & Co | Buy | |
2016-04-15 | Initiated Coverage | FBR & Co. | Outperform | $16.00 |
2016-02-27 | Reiterated Rating | Barrington Research | Buy | |
2016-02-26 | Boost Price Target | Barrington Research | Outperform | $13.00 to $15.00 |
2016-02-26 | Lower Price Target | Jefferies Group | Hold | $12.00 to $11.00 |
2015-11-02 | Lower Price Target | Barclays | Underweight | $15.00 to $12.00 |
2015-11-02 | Lower Price Target | Barrington Research | Outperform | $18.00 to $13.00 |
2015-11-02 | Lower Price Target | Barclays PLC | Underweight | $15.00 to $12.00 |
2015-06-24 | Lower Price Target | Jefferies Group | Hold | $21.00 to $13.00 |
2015-06-21 | Reiterated Rating | William Blair | Outperform | |
2015-06-19 | Lower Price Target | Dougherty & Co | Buy | $25.00 to $15.00 |
2015-06-19 | Lower Price Target | Piper Jaffray | Overweight | $25.50 |
2015-06-19 | Lower Price Target | Piper Jaffray Cos. | Overweight | $25.50 |
2015-06-18 | Reiterated Rating | Stephens | Market Perform | |
2015-06-17 | Initiated Coverage | Oppenheimer | Market Perform | |
2015-06-17 | Initiated Coverage | Oppenheimer Holdings Inc. | Market Perform | |
2015-05-19 | Downgrade | Stifel Nicolaus | Buy to Hold | $25.00 |
2015-02-25 | Reiterated Rating | Jefferies Group | Hold | $16.00 to $21.00 |
2015-02-25 | Boost Price Target | Barclays | Underweight | $9.00 to $15.00 |
2015-02-25 | Boost Price Target | Stifel Nicolaus | Buy | $21.00 to $25.00 |
2015-01-22 | Initiated Coverage | Barrington Research | Outperform | $25.00 |
2014-10-08 | Initiated Coverage | BMO Capital Markets | Outperform | |
2014-07-24 | Upgrade | Dougherty & Co | Neutral to Buy | |
2014-06-19 | Reiterated Rating | Noble Financial | Positive | |
2014-04-25 | Upgrade | Noble Financial | Hold to Buy | $12.00 to $21.00 |
2014-04-25 | Reiterated Rating | Stifel Nicolaus | Buy | $17.00 to $21.00 |
2014-04-09 | Initiated Coverage | Jefferies Group | Hold | $17.00 |
2014-02-14 | Downgrade | Dougherty & Company | Buy to Neutral | |
2014-02-14 | Downgrade | Dougherty & Co | Buy to Neutral | |
2013-10-25 | Reiterated | Dougherty & Company | Buy | $22 to $17 |
2013-10-25 | Lower Price Target | Stifel Nicolaus | Buy | $19.00 to $17.00 |
2013-10-25 | Lower Price Target | Dougherty & Co | Buy | $22.00 to $17.00 |
2013-10-25 | Lower Price Target | Barclays | Underweight | $14.00 to $9.00 |
2013-10-22 | Initiated Coverage | Credit Suisse | Neutral | |
2013-10-02 | Initiated Coverage | Stephens | Underweight | |
2013-09-24 | Downgrade | William Blair | Market Perform | |
2013-02-25 | Upgrade | William Blair | Mkt Perform to Outperform | |
2013-02-08 | Reiterated | Dougherty & Company | Buy | $12 to $16 |
2012-05-07 | Upgrade | Dougherty & Company | Neutral to Buy | $12 to $12 |
2012-02-16 | Reiterated | Stifel Nicolaus | Buy | $13 to $10 |
2011-12-08 | Upgrade | Stifel Nicolaus | Hold to Buy | $13 |
2011-10-25 | Downgrade | Barclays Capital | Equal Weight to Underweight | $19 to $5 |
2011-07-22 | Reiterated | Barclays Capital | Equal Weight | $13 to $19 |
2011-07-22 | Downgrade | JMP Securities | Mkt Perform to Mkt Underperform | $13 |
2016-05-03 | Reiterated Rating | Jefferies Group | Hold | $13.00 |
2016-04-30 | Reiterated Rating | Barrington Research | Buy | |
2016-04-29 | Lower Price Target | Barrington Research | Outperform | $15.00 to $14.00 |
2016-04-29 | Reiterated Rating | FBR & Co. | Buy | |
2016-04-29 | Reiterated Rating | FBR & Co | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HWAY 10 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 2.81M |
BlackRock Institutional Trust Company, N.A. | 0.86M |
EverPoint Asset Management, LLC | 0.41M |
BlackRock Investment Management, LLC | 0.18M |
BlackRock Group LTD | 63438 |
VTL Associates, LLC | 34553 |
BLACKROCK ADVISORS LLC | 17607 |
SpiderRock Trading LLC | 1266 |
SHAPIRO ROBERT N | 136 |
MetLife Securities, Inc | 51 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
LEEDLE BEN R JR CEO | 1.04% (366720) | DVCR / HWAY / |
Farris Michael Chief Commercial Officer | 0.96% (340111) | HWAY / |
CIGARRAN THOMAS G | 0.95% (336726) | AMSG / HWAY / |
NORTH TIDE CAPITAL, LLC | 0.92% (325000) | AFAM / AMED / ELOS / HWAY / SEM / VVUS / |
LUMSDAINE ALFRED Chief Accounting Officer | 0.58% (204215) | HWAY / QHC / |
Tramuto Donato | 0.42% (149596) | HWAY / |
Cigarran Christopher VP, Human Resources | 0.39% (137258) | HWAY / |
Slovenski Sean President, Population Health | 0.29% (101268) | HWAY / |
Michela Matthew A. Chief Operating Officer | 0.26% (92825) | HWAY / |
Cox Thomas COO, Domestic | 0.26% (90795) | HWAY / |
Choueiri Peter President, International | 0.21% (74546) | HWAY / |
Stolz Sidney W President, Network Solutions | 0.19% (68531) | HWAY / |
Flipse Mary General Counsel | 0.13% (45167) | HWAY / |
Alison Taunton-Rigby | 0.12% (43105) | HWAY / |
Hargreaves Glenn Chief Accounting Officer | 0.11% (40404) | HWAY / |
Greczyn Robert J Jr | 0.10% (33590) | HWAY / LPDX / |
CHAPUT MARY A CFO | 0.08% (29868) | HWAY / |
Wickens John A | 0.07% (25769) | HWAY / |
Wills Kevin | 0.07% (24169) | COH / HWAY / |
Novelli William | 0.07% (23535) | HWAY / |
SHAPIRO LEE | 0.07% (23215) | HWAY / MDRX / MDSO / |
England Mary Jane | 0.06% (19453) | HWAY / |
Keckley Paul H. | 0.05% (17590) | HWAY / |
KARRO BRADLEY S | 0.05% (17590) | EMAG / HWAY / |
NEEL C WARREN | 0.04% (13663) | HWAY / |
BALLANTINE JOHN W | 0.04% (13663) | HWAY / POR / |
Elrod James W VP, General Counsel | 0.04% (12500) | HWAY / |
ONEIL WILLIAM C | 0.03% (11737) | DVCR / HWAY / |
Hudson Peter A | 0.03% (11387) | HWAY / |
Feldshon Archelle Georgiou | 0.03% (11387) | HWAY / PRGX / |
BISGARD JAY C | 0.03% (10280) | HWAY / |
Holland Adam C CFO | 0.02% (6596) | HWAY / KIRK / |
Brueckner Stefen F. President & COO | 0.02% (5394) | HWAY / |
KELLIHER MATTHEW President, International | 0.01% (2274) | HWAY / |